Detalhe da pesquisa
1.
Impact of scFv on functionality and safety of third generation CD123 CAR T cells.
Cancer Immunol Res
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38819256
2.
Conventional Therapeutics in BPDCN Patients-Do They Still Have a Place in the Era of Targeted Therapies?
Cancers (Basel)
; 14(15)2022 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954431
3.
Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells.
Cancers (Basel)
; 14(13)2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804941
4.
BPDCN: When polychemotherapy does not compromise allogeneic CD123 CAR-T cell cytotoxicity.
EJHaem
; 2(1): 125-130, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35846081
5.
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm.
Leukemia
; 34(12): 3228-3241, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32111969